Oncostatin M in combination with tumor necrosis factor α induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo

被引:99
作者
Hui, W
Rowan, AD [1 ]
Richards, CD
Cawston, TE
机构
[1] Univ Newcastle, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] McMaster Univ, Hamilton, ON, Canada
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 12期
关键词
D O I
10.1002/art.11333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine the effects of the proinflammatory cytokine combination of oncostatin M (OSM) and tumor necrosis factor alpha (TNFalpha) on cartilage destruction in both in vitro and in vivo model systems. Methods. The release of collagen and proteoglycan was assessed in bovine cartilage explant cultures, while messenger RNA (mRNA) from bovine chondrocytes was analyzed by Northern blotting. Immunohistochemistry was performed on sections prepared from murine joints following injection of adenovirus vectors encoding murine OSM and/or murine TNFalpha. Results. The combination of OSM + TNFalpha induced significant collagen release from bovine cartilage, accompanied by high levels of active collagenolytic activity. Northern blot analysis indicated that this cytokine combination synergistically induced matrix metalloproteinase 1 (MMP-1), MMP-3, and MMP-13 mRNA. The in vivo data clearly indicated that OSM + TNFalpha overexpression increased MMP levels and decreased levels of tissue inhibitor of metalloproteinases 1 (TIMP-1). Specifically, OSM + TNFalpha induced marked synovial hyperplasia, inflammation, and cartilage and bone destruction with a concomitant increase in MMP expression in both cartilage and synovium and decreased TIMP-1 expression in the articular cartilage. These effects were markedly greater than those seen with either cytokine alone. Conclusion. This study demonstrates that OSM + TNFalpha represents a potent proinflammatory cytokine combination that markedly induces MMP production in both cartilage and synovium, thus promoting joint destruction.
引用
收藏
页码:3404 / 3418
页数:15
相关论文
共 61 条
  • [1] A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth
    AnandApte, B
    Bao, L
    Smith, R
    Iwata, K
    Olsen, BR
    Zetter, B
    Apte, SS
    [J]. BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1996, 74 (06): : 853 - 862
  • [2] Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation
    Balbín, M
    Fueyo, A
    Knäuper, V
    López, JM
    Alvarez, J
    Sánchez, LM
    Quesada, V
    Bordallo, J
    Murphy, G
    López-Otín, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) : 10253 - 10262
  • [3] Bell MC, 1999, ARTHRITIS RHEUM, V42, P2543, DOI 10.1002/1529-0131(199912)42:12<2543::AID-ANR6>3.0.CO
  • [4] 2-W
  • [5] 2 IMPROVED AND SIMPLIFIED METHODS FOR SPECTROPHOTOMETRIC DETERMINATION OF HYDROXYPROLINE
    BERGMAN, I
    LOXLEY, R
    [J]. ANALYTICAL CHEMISTRY, 1963, 35 (12) : 1961 - &
  • [6] AN EFFICIENT AND FLEXIBLE SYSTEM FOR CONSTRUCTION OF ADENOVIRUS VECTORS WITH INSERTIONS OR DELETIONS IN EARLY REGION-1 AND REGION-3
    BETT, AJ
    HADDARA, W
    PREVEC, L
    GRAHAM, FL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) : 8802 - 8806
  • [7] Bigg Heather F., 2001, Current Opinion in Pharmacology, V1, P314, DOI 10.1016/S1471-4892(01)00055-8
  • [8] Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
    Billinghurst, RC
    Dahlberg, L
    Ionescu, M
    Reiner, A
    Bourne, R
    Rorabeck, C
    Mitchell, P
    Hambor, J
    Diekmann, O
    Tschesche, H
    Chen, J
    VanWart, H
    Poole, AR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) : 1534 - 1545
  • [9] An aggrecan-degrading activity associated with chondrocyte membranes
    Billington, CJ
    Clark, IM
    Cawston, TE
    [J]. BIOCHEMICAL JOURNAL, 1998, 336 : 207 - 212
  • [10] Brennan FM, 1997, BRIT J RHEUMATOL, V36, P643